Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit

被引:8
|
作者
Nartey, Yvonne [1 ]
Stewart, Iain [2 ]
Khakwani, Aamir [1 ]
Beattie, Vanessa [3 ]
Wilcock, Andrew [4 ,5 ]
Woolhouse, Ian [6 ]
Beckett, Paul [7 ]
Hubbard, Richard B. [1 ]
Tata, Laila J. [1 ]
机构
[1] Univ Nottingham, Nottingham City Hosp, Div Epidemiol & Publ Hlth, Clin Sci Bldg, Nottingham NG5 1PB, England
[2] Univ Nottingham, Nottingham City Hosp, Div Resp Med, Clin Sci Bldg, Nottingham NG5 1PB, England
[3] Aintree Univ Hosp NHS Fdn Trust, Longmoor Lane, Liverpool L9 7AL, Merseyside, England
[4] Nottingham Univ Hosp, Hayward House, Nottingham, England
[5] Univ Nottingham, Nottingham, England
[6] Queen Elizabeth Hosp Birmingham, Mindelsohn Way, Birmingham B15 2GW, W Midlands, England
[7] Univ Hosp Derby & Burton NHS Fdn Trust, Uttoxeter Rd, Derby DE22 3NE, England
关键词
Patient experience; Patient view; CPES; Lung cancer; England; EUROPE; 1999-2007; CARE; QUALITY; SURVIVAL; PATTERNS; NONRESPONSE; IMPACT;
D O I
10.1016/j.lungcan.2019.11.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Healthcare systems increasingly recognise the importance of service users' perspectives for improving care organisation and delivery. The English Cancer Patient Experience Survey (CPES) is carried out annually, however, its representativeness within cancer types is unknown. We have explored if the CPES results are representative of people with lung cancer. Materials and methods: We linked cancer registry data across multiple sources to assess how CPES represents sociodemographic and clinical characteristics of the National Lung Cancer Audit population, accounting for post-sampling mortality bias. Multivariable logistic regression was used to compare people included and not included in CPES. Results: Of 240,375 people diagnosed (2009-2015), 15,967 (7 %) were included in CPES. Gender and ethnicity were reasonably represented, as were sociodemographic and clinical groupings, although more received anti-cancer treatment (96 % of CPES respondents vs. 56 % of patients nationally; adjusted odds ratio = 10.3, 95 confidence interval 9.4-11.2 for any anti-cancer treatment) with chemotherapy most over-represented, followed by surgery and then radiotherapy. CPES under-represented older, more socioeconomically deprived, and certain clinical groups, including those with worse performance status, multiple comorbidities, and diagnosis via emergency presentation. Conclusion: CPES includes patients across the sociodemographic and clinical spectrum indicating its value for research and service planning. Unbalanced representation of incident lung cancer cases is a limitation that must be considered in context of using CPES findings to implement service changes. Although half the national lung cancer population who received no anti-cancer treatment do not have their experiences represented, the strength of this dataset is in providing detailed comparisons of patient experiences across different treatment groups.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [1] Are people with mesothelioma who respond to the English Cancer Patient Experience Survey representative of the national mesothelioma population? A data comparison with cancer registry patients from the National Lung Cancer Audit
    Nartey, Yvonne
    Stewart, Iain
    Beattie, Vanessa
    Wilcock, Andrew
    Beckett, Paul
    Hubbard, Richard
    Tata, Laila J.
    INTERNATIONAL JOURNAL OF NURSING STUDIES ADVANCES, 2022, 4
  • [2] Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English Cancer Patient Experience Survey linked with the national cancer registry
    Nartey, Yvonne
    Tata, Laila J.
    Khakwani, Aamir
    Beattie, Vanessa
    Beckett, Paul
    Hubbard, Richard B.
    Stewart, Iain
    SUPPORTIVE CARE IN CANCER, 2022, 30 (05) : 4417 - 4428
  • [3] Using patient experiences to evaluate care and expectations in lung cancer: analysis of the English Cancer Patient Experience Survey linked with the national cancer registry
    Yvonne Nartey
    Laila J. Tata
    Aamir Khakwani
    Vanessa Beattie
    Paul Beckett
    Richard B. Hubbard
    Iain Stewart
    Supportive Care in Cancer, 2022, 30 : 4417 - 4428
  • [4] Barriers to delivering advanced cancer nursing: A workload analysis of specialist nurse practice linked to the English National Lung Cancer Audit
    Stewart, Iain
    Leary, Alison
    Tod, Angela
    Borthwick, Diana
    Khakwani, Aamir
    Hubbard, Richard
    Beckett, Paul
    Tata, Laila J.
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2018, 36 : 103 - 111
  • [5] Early mortality after surgical resection for lung cancer: an analysis of the English National Lung cancer audit
    Powell, Helen A.
    Tata, Laila J.
    Baldwin, David R.
    Stanley, Rosamund A.
    Khakwani, Aamir
    Hubbard, Richard B.
    THORAX, 2013, 68 (09) : 826 - 834
  • [6] Age-related experiences of colorectal cancer diagnosis: a secondary analysis of the English National Cancer Patient Experience Survey
    Owais, Syeda Somyyah
    Arnolda, Gaston
    Lamprell, Klay
    Liauw, Winston
    Delaney, Geoff P.
    Olver, Ian
    Karnon, Jonathan
    Braithwaite, Jeffrey
    BMJ OPEN GASTROENTEROLOGY, 2023, 10 (01):
  • [7] Do working practices of cancer nurse specialists improve clinical outcomes? Retrospective cohort analysis from the English National Lung Cancer Audit
    Stewart, Iain
    Leary, Alison
    Khakwani, Aamir
    Borthwick, Diana
    Tod, Angela
    Hubbard, Richard
    Beckett, Paul
    Tata, Laila J.
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2021, 118
  • [8] The underlying structure of the English Cancer Patient Experience Survey: Factor analysis to support survey reporting and design
    Gomez-Cano, Mayam
    Lyratzopoulos, Georgios
    Campbell, John L.
    N. Elliott, Marc
    A. Abel, Gary
    CANCER MEDICINE, 2022, 11 (01): : 3 - 20
  • [9] Analysis of local qualitative cancer patient experience alongside the 2019 results of the UK National Cancer Patient Experience Survey
    Dalby, Melanie
    Hill, Alison
    Nabhani-Gebara, Shereen
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2022, 30 (02) : 169 - 174
  • [10] Results of the Austrian National Lung Cancer Audit
    Burghuber, Otto C.
    Kirchbacher, Klaus
    Mohn-Staudner, Andrea
    Hochmair, Maximilian
    Breyer, Marie-Kathrin
    Studnicka, Michael
    Mueller, Michael Rolf
    Feurstein, Petra
    Schrott, Andrea
    Lamprecht, Bernd
    Eckmayr, Josef
    Renner, Friedrich
    Bolitschek, Josef
    Pohl, Wolfgang
    Schenk, Peter
    Errhalt, Peter
    Cerkl, Peter
    Baumgartner, Bernhard
    Kneussl, Meinhard
    Hartl, Sylvia
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2020, 14